Angiotensin converting enzyme inhibitors – enalapril

Generic name	enalapril, including in combination with hydrochlorothiazide
Strength	2.5 mg, 5 mg, 10 mg, 20 mg, 5mg/12.5mg, 10 mg/25 mg
Form	tablet

Special Authority criteria	Approval period
1. Treatment failure of, or intolerance to, ramipril OR 2. Complex patient requiring medications for co-existing chronic condition(s)	Indefinite

Practitioner exemptions

• Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
  • Pediatrics
  • Pediatric cardiology

Special notes

• Individuals requiring a diuretic combination product must satisfy the same criteria
• Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria

Special Authority request form(s)

• Log in to eForms
• 5328 - General Special Authority Report (PDF, 656KB)